世界の球形細胞白質ジストロフィー治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Globoid Cell Leukodystrophy Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z2589
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、98ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、球形細胞白質ジストロフィー治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（RND-001、CMB-200、DUOC-01、その他）、用途別市場規模（病院、クリニック、研究センター）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・球形細胞白質ジストロフィー治療の市場動向
・企業の競争状況、市場シェア
・球形細胞白質ジストロフィー治療の種類別市場規模（RND-001、CMB-200、DUOC-01、その他）
・球形細胞白質ジストロフィー治療の用途別市場規模（病院、クリニック、研究センター）
・球形細胞白質ジストロフィー治療の北米市場規模2016-2027（アメリカ、カナダ）
・球形細胞白質ジストロフィー治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・球形細胞白質ジストロフィー治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・球形細胞白質ジストロフィー治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・球形細胞白質ジストロフィー治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Commence Bio Inc、Kyorin Pharmaceutical Co Ltd、Novartis AG、Nuo Therapeutics Inc）
・結論

Market Analysis and Insights: Global Globoid Cell Leukodystrophy Treatment Market
The global Globoid Cell Leukodystrophy Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Globoid Cell Leukodystrophy Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Globoid Cell Leukodystrophy Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Globoid Cell Leukodystrophy Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Globoid Cell Leukodystrophy Treatment market.

Global Globoid Cell Leukodystrophy Treatment Scope and Market Size
Globoid Cell Leukodystrophy Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Globoid Cell Leukodystrophy Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
RND-001
CMB-200
DUOC-01
Others

Segment by Application
Hospital
Clinic
Research Center

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Commence Bio Inc
Kyorin Pharmaceutical Co Ltd
Novartis AG

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Globoid Cell Leukodystrophy Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 RND-001
1.2.3 CMB-200
1.2.4 DUOC-01
1.2.5 Others
1.3 Market by Application
1.3.1 Global Globoid Cell Leukodystrophy Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Research Center
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Globoid Cell Leukodystrophy Treatment Market Perspective (2016-2027)
2.2 Globoid Cell Leukodystrophy Treatment Growth Trends by Regions
2.2.1 Globoid Cell Leukodystrophy Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Globoid Cell Leukodystrophy Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Globoid Cell Leukodystrophy Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Globoid Cell Leukodystrophy Treatment Industry Dynamic
2.3.1 Globoid Cell Leukodystrophy Treatment Market Trends
2.3.2 Globoid Cell Leukodystrophy Treatment Market Drivers
2.3.3 Globoid Cell Leukodystrophy Treatment Market Challenges
2.3.4 Globoid Cell Leukodystrophy Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Globoid Cell Leukodystrophy Treatment Players by Revenue
3.1.1 Global Top Globoid Cell Leukodystrophy Treatment Players by Revenue (2016-2021)
3.1.2 Global Globoid Cell Leukodystrophy Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Globoid Cell Leukodystrophy Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Globoid Cell Leukodystrophy Treatment Revenue
3.4 Global Globoid Cell Leukodystrophy Treatment Market Concentration Ratio
3.4.1 Global Globoid Cell Leukodystrophy Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Globoid Cell Leukodystrophy Treatment Revenue in 2020
3.5 Globoid Cell Leukodystrophy Treatment Key Players Head office and Area Served
3.6 Key Players Globoid Cell Leukodystrophy Treatment Product Solution and Service
3.7 Date of Enter into Globoid Cell Leukodystrophy Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Globoid Cell Leukodystrophy Treatment Breakdown Data by Type
4.1 Global Globoid Cell Leukodystrophy Treatment Historic Market Size by Type (2016-2021)
4.2 Global Globoid Cell Leukodystrophy Treatment Forecasted Market Size by Type (2022-2027)

5 Globoid Cell Leukodystrophy Treatment Breakdown Data by Application
5.1 Global Globoid Cell Leukodystrophy Treatment Historic Market Size by Application (2016-2021)
5.2 Global Globoid Cell Leukodystrophy Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Globoid Cell Leukodystrophy Treatment Market Size (2016-2027)
6.2 North America Globoid Cell Leukodystrophy Treatment Market Size by Type
6.2.1 North America Globoid Cell Leukodystrophy Treatment Market Size by Type (2016-2021)
6.2.2 North America Globoid Cell Leukodystrophy Treatment Market Size by Type (2022-2027)
6.2.3 North America Globoid Cell Leukodystrophy Treatment Market Size by Type (2016-2027)
6.3 North America Globoid Cell Leukodystrophy Treatment Market Size by Application
6.3.1 North America Globoid Cell Leukodystrophy Treatment Market Size by Application (2016-2021)
6.3.2 North America Globoid Cell Leukodystrophy Treatment Market Size by Application (2022-2027)
6.3.3 North America Globoid Cell Leukodystrophy Treatment Market Size by Application (2016-2027)
6.4 North America Globoid Cell Leukodystrophy Treatment Market Size by Country
6.4.1 North America Globoid Cell Leukodystrophy Treatment Market Size by Country (2016-2021)
6.4.2 North America Globoid Cell Leukodystrophy Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Globoid Cell Leukodystrophy Treatment Market Size (2016-2027)
7.2 Europe Globoid Cell Leukodystrophy Treatment Market Size by Type
7.2.1 Europe Globoid Cell Leukodystrophy Treatment Market Size by Type (2016-2021)
7.2.2 Europe Globoid Cell Leukodystrophy Treatment Market Size by Type (2022-2027)
7.2.3 Europe Globoid Cell Leukodystrophy Treatment Market Size by Type (2016-2027)
7.3 Europe Globoid Cell Leukodystrophy Treatment Market Size by Application
7.3.1 Europe Globoid Cell Leukodystrophy Treatment Market Size by Application (2016-2021)
7.3.2 Europe Globoid Cell Leukodystrophy Treatment Market Size by Application (2022-2027)
7.3.3 Europe Globoid Cell Leukodystrophy Treatment Market Size by Application (2016-2027)
7.4 Europe Globoid Cell Leukodystrophy Treatment Market Size by Country
7.4.1 Europe Globoid Cell Leukodystrophy Treatment Market Size by Country (2016-2021)
7.4.2 Europe Globoid Cell Leukodystrophy Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Globoid Cell Leukodystrophy Treatment Market Size (2016-2027)
8.2 Asia-Pacific Globoid Cell Leukodystrophy Treatment Market Size by Type
8.2.1 Asia-Pacific Globoid Cell Leukodystrophy Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Globoid Cell Leukodystrophy Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Globoid Cell Leukodystrophy Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Globoid Cell Leukodystrophy Treatment Market Size by Application
8.3.1 Asia-Pacific Globoid Cell Leukodystrophy Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Globoid Cell Leukodystrophy Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Globoid Cell Leukodystrophy Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Globoid Cell Leukodystrophy Treatment Market Size by Region
8.4.1 Asia-Pacific Globoid Cell Leukodystrophy Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Globoid Cell Leukodystrophy Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Globoid Cell Leukodystrophy Treatment Market Size (2016-2027)
9.2 Latin America Globoid Cell Leukodystrophy Treatment Market Size by Type
9.2.1 Latin America Globoid Cell Leukodystrophy Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Globoid Cell Leukodystrophy Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Globoid Cell Leukodystrophy Treatment Market Size by Type (2016-2027)
9.3 Latin America Globoid Cell Leukodystrophy Treatment Market Size by Application
9.3.1 Latin America Globoid Cell Leukodystrophy Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Globoid Cell Leukodystrophy Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Globoid Cell Leukodystrophy Treatment Market Size by Application (2016-2027)
9.4 Latin America Globoid Cell Leukodystrophy Treatment Market Size by Country
9.4.1 Latin America Globoid Cell Leukodystrophy Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Globoid Cell Leukodystrophy Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Globoid Cell Leukodystrophy Treatment Market Size (2016-2027)
10.2 Middle East & Africa Globoid Cell Leukodystrophy Treatment Market Size by Type
10.2.1 Middle East & Africa Globoid Cell Leukodystrophy Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Globoid Cell Leukodystrophy Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Globoid Cell Leukodystrophy Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Globoid Cell Leukodystrophy Treatment Market Size by Application
10.3.1 Middle East & Africa Globoid Cell Leukodystrophy Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Globoid Cell Leukodystrophy Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Globoid Cell Leukodystrophy Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Globoid Cell Leukodystrophy Treatment Market Size by Country
10.4.1 Middle East & Africa Globoid Cell Leukodystrophy Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Globoid Cell Leukodystrophy Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Commence Bio Inc
11.1.1 Commence Bio Inc Company Details
11.1.2 Commence Bio Inc Business Overview
11.1.3 Commence Bio Inc Globoid Cell Leukodystrophy Treatment Introduction
11.1.4 Commence Bio Inc Revenue in Globoid Cell Leukodystrophy Treatment Business (2016-2021)
11.1.5 Commence Bio Inc Recent Development
11.2 Kyorin Pharmaceutical Co Ltd
11.2.1 Kyorin Pharmaceutical Co Ltd Company Details
11.2.2 Kyorin Pharmaceutical Co Ltd Business Overview
11.2.3 Kyorin Pharmaceutical Co Ltd Globoid Cell Leukodystrophy Treatment Introduction
11.2.4 Kyorin Pharmaceutical Co Ltd Revenue in Globoid Cell Leukodystrophy Treatment Business (2016-2021)
11.2.5 Kyorin Pharmaceutical Co Ltd Recent Development
11.3 Novartis AG
11.3.1 Novartis AG Company Details
11.3.2 Novartis AG Business Overview
11.3.3 Novartis AG Globoid Cell Leukodystrophy Treatment Introduction
11.3.4 Novartis AG Revenue in Globoid Cell Leukodystrophy Treatment Business (2016-2021)
11.3.5 Novartis AG Recent Development
11.4 Nuo Therapeutics Inc
11.4.1 Nuo Therapeutics Inc Company Details
11.4.2 Nuo Therapeutics Inc Business Overview
11.4.3 Nuo Therapeutics Inc Globoid Cell Leukodystrophy Treatment Introduction
11.4.4 Nuo Therapeutics Inc Revenue in Globoid Cell Leukodystrophy Treatment Business (2016-2021)
11.4.5 Nuo Therapeutics Inc Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Globoid Cell Leukodystrophy Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of RND-001
Table 3. Key Players of CMB-200
Table 4. Key Players of DUOC-01
Table 5. Key Players of Others
Table 6. Global Globoid Cell Leukodystrophy Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Globoid Cell Leukodystrophy Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Globoid Cell Leukodystrophy Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Globoid Cell Leukodystrophy Treatment Market Share by Regions (2016-2021)
Table 10. Global Globoid Cell Leukodystrophy Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Globoid Cell Leukodystrophy Treatment Market Share by Regions (2022-2027)
Table 12. Globoid Cell Leukodystrophy Treatment Market Trends
Table 13. Globoid Cell Leukodystrophy Treatment Market Drivers
Table 14. Globoid Cell Leukodystrophy Treatment Market Challenges
Table 15. Globoid Cell Leukodystrophy Treatment Market Restraints
Table 16. Global Globoid Cell Leukodystrophy Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Globoid Cell Leukodystrophy Treatment Market Share by Players (2016-2021)
Table 18. Global Top Globoid Cell Leukodystrophy Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Globoid Cell Leukodystrophy Treatment as of 2020)
Table 19. Ranking of Global Top Globoid Cell Leukodystrophy Treatment Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Globoid Cell Leukodystrophy Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Globoid Cell Leukodystrophy Treatment Product Solution and Service
Table 23. Date of Enter into Globoid Cell Leukodystrophy Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Globoid Cell Leukodystrophy Treatment Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Globoid Cell Leukodystrophy Treatment Revenue Market Share by Type (2016-2021)
Table 27. Global Globoid Cell Leukodystrophy Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Globoid Cell Leukodystrophy Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Globoid Cell Leukodystrophy Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Globoid Cell Leukodystrophy Treatment Revenue Market Share by Application (2016-2021)
Table 31. Global Globoid Cell Leukodystrophy Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Globoid Cell Leukodystrophy Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Globoid Cell Leukodystrophy Treatment Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Globoid Cell Leukodystrophy Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Globoid Cell Leukodystrophy Treatment Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Globoid Cell Leukodystrophy Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Globoid Cell Leukodystrophy Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Globoid Cell Leukodystrophy Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Globoid Cell Leukodystrophy Treatment Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Globoid Cell Leukodystrophy Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Globoid Cell Leukodystrophy Treatment Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Globoid Cell Leukodystrophy Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Globoid Cell Leukodystrophy Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Globoid Cell Leukodystrophy Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Globoid Cell Leukodystrophy Treatment Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Globoid Cell Leukodystrophy Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Globoid Cell Leukodystrophy Treatment Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Globoid Cell Leukodystrophy Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Globoid Cell Leukodystrophy Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Globoid Cell Leukodystrophy Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Globoid Cell Leukodystrophy Treatment Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Globoid Cell Leukodystrophy Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Globoid Cell Leukodystrophy Treatment Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Globoid Cell Leukodystrophy Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Globoid Cell Leukodystrophy Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Globoid Cell Leukodystrophy Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Globoid Cell Leukodystrophy Treatment Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Globoid Cell Leukodystrophy Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Globoid Cell Leukodystrophy Treatment Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Globoid Cell Leukodystrophy Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Globoid Cell Leukodystrophy Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Globoid Cell Leukodystrophy Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 63. Commence Bio Inc Company Details
Table 64. Commence Bio Inc Business Overview
Table 65. Commence Bio Inc Globoid Cell Leukodystrophy Treatment Product
Table 66. Commence Bio Inc Revenue in Globoid Cell Leukodystrophy Treatment Business (2016-2021) & (US$ Million)
Table 67. Commence Bio Inc Recent Development
Table 68. Kyorin Pharmaceutical Co Ltd Company Details
Table 69. Kyorin Pharmaceutical Co Ltd Business Overview
Table 70. Kyorin Pharmaceutical Co Ltd Globoid Cell Leukodystrophy Treatment Product
Table 71. Kyorin Pharmaceutical Co Ltd Revenue in Globoid Cell Leukodystrophy Treatment Business (2016-2021) & (US$ Million)
Table 72. Kyorin Pharmaceutical Co Ltd Recent Development
Table 73. Novartis AG Company Details
Table 74. Novartis AG Business Overview
Table 75. Novartis AG Globoid Cell Leukodystrophy Treatment Product
Table 76. Novartis AG Revenue in Globoid Cell Leukodystrophy Treatment Business (2016-2021) & (US$ Million)
Table 77. Novartis AG Recent Development
Table 78. Nuo Therapeutics Inc Company Details
Table 79. Nuo Therapeutics Inc Business Overview
Table 80. Nuo Therapeutics Inc Globoid Cell Leukodystrophy Treatment Product
Table 81. Nuo Therapeutics Inc Revenue in Globoid Cell Leukodystrophy Treatment Business (2016-2021) & (US$ Million)
Table 82. Nuo Therapeutics Inc Recent Development
Table 83. Research Programs/Design for This Report
Table 84. Key Data Information from Secondary Sources
Table 85. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Globoid Cell Leukodystrophy Treatment Market Share by Type: 2020 VS 2027
Figure 2. RND-001 Features
Figure 3. CMB-200 Features
Figure 4. DUOC-01 Features
Figure 5. Others Features
Figure 6. Global Globoid Cell Leukodystrophy Treatment Market Share by Application: 2020 VS 2027
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Research Center Case Studies
Figure 10. Globoid Cell Leukodystrophy Treatment Report Years Considered
Figure 11. Global Globoid Cell Leukodystrophy Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Globoid Cell Leukodystrophy Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Globoid Cell Leukodystrophy Treatment Market Share by Regions: 2020 VS 2027
Figure 14. Global Globoid Cell Leukodystrophy Treatment Market Share by Regions (2022-2027)
Figure 15. Global Globoid Cell Leukodystrophy Treatment Market Share by Players in 2020
Figure 16. Global Top Globoid Cell Leukodystrophy Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Globoid Cell Leukodystrophy Treatment as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Globoid Cell Leukodystrophy Treatment Revenue in 2020
Figure 18. Global Globoid Cell Leukodystrophy Treatment Revenue Market Share by Type (2016-2021)
Figure 19. Global Globoid Cell Leukodystrophy Treatment Revenue Market Share by Type (2022-2027)
Figure 20. North America Globoid Cell Leukodystrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Globoid Cell Leukodystrophy Treatment Market Share by Type (2016-2027)
Figure 22. North America Globoid Cell Leukodystrophy Treatment Market Share by Application (2016-2027)
Figure 23. North America Globoid Cell Leukodystrophy Treatment Market Share by Country (2016-2027)
Figure 24. United States Globoid Cell Leukodystrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Globoid Cell Leukodystrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Globoid Cell Leukodystrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Globoid Cell Leukodystrophy Treatment Market Share by Type (2016-2027)
Figure 28. Europe Globoid Cell Leukodystrophy Treatment Market Share by Application (2016-2027)
Figure 29. Europe Globoid Cell Leukodystrophy Treatment Market Share by Country (2016-2027)
Figure 30. Germany Globoid Cell Leukodystrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Globoid Cell Leukodystrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Globoid Cell Leukodystrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Globoid Cell Leukodystrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Globoid Cell Leukodystrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Globoid Cell Leukodystrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Globoid Cell Leukodystrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Globoid Cell Leukodystrophy Treatment Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Globoid Cell Leukodystrophy Treatment Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Globoid Cell Leukodystrophy Treatment Market Share by Region (2016-2027)
Figure 40. China Globoid Cell Leukodystrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Globoid Cell Leukodystrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Globoid Cell Leukodystrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Globoid Cell Leukodystrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Globoid Cell Leukodystrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Globoid Cell Leukodystrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Globoid Cell Leukodystrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Globoid Cell Leukodystrophy Treatment Market Share by Type (2016-2027)
Figure 48. Latin America Globoid Cell Leukodystrophy Treatment Market Share by Application (2016-2027)
Figure 49. Latin America Globoid Cell Leukodystrophy Treatment Market Share by Country (2016-2027)
Figure 50. Mexico Globoid Cell Leukodystrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Globoid Cell Leukodystrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Globoid Cell Leukodystrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Globoid Cell Leukodystrophy Treatment Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Globoid Cell Leukodystrophy Treatment Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Globoid Cell Leukodystrophy Treatment Market Share by Country (2016-2027)
Figure 56. Turkey Globoid Cell Leukodystrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Globoid Cell Leukodystrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Globoid Cell Leukodystrophy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Commence Bio Inc Revenue Growth Rate in Globoid Cell Leukodystrophy Treatment Business (2016-2021)
Figure 60. Kyorin Pharmaceutical Co Ltd Revenue Growth Rate in Globoid Cell Leukodystrophy Treatment Business (2016-2021)
Figure 61. Novartis AG Revenue Growth Rate in Globoid Cell Leukodystrophy Treatment Business (2016-2021)
Figure 62. Nuo Therapeutics Inc Revenue Growth Rate in Globoid Cell Leukodystrophy Treatment Business (2016-2021)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed

以下、関連資料のご紹介

世界の基底細胞がん治療市場規模・現状・予測（2021年-2027年）

Global Basal Cell Carcinoma Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0707 2021年4月 98Pages
QYResearch社発行の本調査資料では、基底細胞がん治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（局所治療、ヘッジホッグ経路阻害剤療法、モース手術、その他手術、その他治療）、用途別市場規模（病院、専門クリニック、その他）、主要地域別市...

世界の基底細胞皮膚がん治療市場規模・現状・予測（2021年-2027年）

Global Basal Cell Skin Cancer Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0708 2021年4月 98Pages
QYResearch社発行の本調査資料では、基底細胞皮膚がん治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（局所治療、ヘッジホッグ経路阻害剤療法、モース手術、その他）、用途別市場規模（病院、専門クリニック、その他）、主要地域別市場規模（北米...

世界の基底細胞皮膚がん治療市場規模・現状・予測（2021年-2027年）

世界の小細胞肺がん治療薬市場規模・現状・予測（2021年-2027年）

Global Small Cell Lung Cancer Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z5296 2021年4月 93Pages
QYResearch社発行の本調査資料では、小細胞肺がん治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（オート麦がん、コンバイナー小細胞がん）、用途別市場規模（手術、放射線療法、化学療法）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、...

世界の小細胞肺がん治療薬市場規模・現状・予測（2021年-2027年）

世界の形質細胞新生物治療市場規模・現状・予測（2021年-2027年）

Global Plasma Cell Neoplasm Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z4637 2021年4月 98Pages
QYResearch社発行の本調査資料では、形質細胞新生物治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（放射線療法、化学療法、生物学的製剤、標的療法）、用途別市場規模（病院、専門クリニック、外来手術センター）、主要地域別市場規模（北米、ア...

世界の巨細胞性動脈炎治療市場規模・現状・予測（2021年-2027年）

Global Giant Cell Arteritis Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z2570 2021年4月 94Pages
QYResearch社発行の本調査資料では、巨細胞性動脈炎治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（コルチコステロイド療法、アジュバント剤）、用途別市場規模（病院、クリニック、ASC、その他）、主要地域別市場規模（北米、アメリカ、ヨー...

世界のメルケル細胞癌治療市場規模・現状・予測（2021年-2027年）

Global Merkel Cell Carcinoma Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3708 2021年4月 95Pages
QYResearch社発行の本調査資料では、メルケル細胞癌治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、免疫療法、併用療法、その他）、用途別市場規模（病院、外来手術センター、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッ...

世界の鎌状赤血球症治療市場規模・現状・予測（2021年-2027年）

Global Sickle Cell Disease Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z5231 2021年4月 92Pages
QYResearch社発行の本調査資料では、鎌状赤血球症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（鎌状赤血球貧血、シックルベータサラセミア、シックルヘモグロビンC病）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、...

世界の有毛細胞白血病治療市場規模・現状・予測（2021年-2027年）

Global Hairy cell Leukemia Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z2658 2021年4月 90Pages
QYResearch社発行の本調査資料では、有毛細胞白血病治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（化学療法薬、免疫療法薬）、用途別市場規模（病院、薬局、がん研究機構）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中...

世界の巨細胞性動脈炎治療市場規模・現状・予測（2021年-2027年） Giant cell arteritis is also known as temporal arteritis, is a type of disease which causes inflammation of medium and large vessels that occurs only in individuals older than 50 years of age. Seasonal variations in the incidence of giant cell arteritis treatment suggest a possible infective origin …
世界の基底細胞がん治療市場規模・現状・予測（2021年-2027年） Basal cell carcinoma (BCC) is the most common type of skin cancer. It’s also the most commonly diagnosed cancer in the United States. Every year, millions of people learn that they have BCC. Basal cell carcinoma that is superficial and doesn't extend very far into the skin may be treated with creams…
世界の基底細胞皮膚がん治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Basal Cell Skin Cancer Treatment Market The global Basal Cell Skin Cancer Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data…
世界の基底細胞皮膚がん治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Basal Cell Skin Cancer Treatment Market The global Basal Cell Skin Cancer Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data…
世界の小細胞肺がん治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Small Cell Lung Cancer Treatment Market The global Small Cell Lung Cancer Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data…